Laurence joined Westwicke Partners in 2015 as a member of the life science team where he assists both private and public companies in the biotech and specialty pharmaceutical sectors. His experience spans both the equity and fixed income buy and sell sides, placing him an in ideal position to advise on cultivating strategic relationships.
Laurence joined Westwicke Partners’ Life Sciences team in January 2015. He has 10 years of Wall Street experience on both the buy side and the sell side, having worked as an equity and fixed-income analyst for J.P. Morgan Cazenove, ING Group (in both London and Singapore), and Barclays Capital.
As a life-long generalist, he knows the importance of targeted corporate messaging and of transparent, accessible and professional investor relations. He is also deeply knowledgeable of the myriad relationships that must be cultivated for a publicly listed company to be heard and to thrive. He advises companies across all aspects of the investor relations value chain.
Laurence studied economics at Queens’ College, Cambridge University, England, where he received a BA and MA in Economics.